Global Whole Genome Amplification Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Whole Genome Amplification Market is presumed to reach the market size of nearly USD 7.07 Million by 2032 from USD 3.41 Million in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Whole-genome amplification (WGA) is a process where an entire genome gets amplified. The quantity of DNA which remains in nanograms at the beginning of the process gets converted into micrograms of amplified products. It works on the principles of polymerase chain reaction, which enzymatically replicates the DNA from the genome specimen. WGA is considered an important tool as it increases the limited number of DNA specimens with the help of a small quantity of genomic DNA. It is very useful for studying the gene of an organism, which is done with the conserved limited specimen. This procedure is widely used in a number of applications.

MARKET DYNAMICS

The increasing application of whole genome amplification in various fields is a key factor driving the WGA market. The WGA is expected to witness favorable growth owing to the increasing use of WGA for diagnosing genetic disorders and embryonic disorders, genotyping, forensic, and analysis of old DNA samples. Furthermore, increasing awareness about WGA, a considerable amount of investment for clinical trials and application in molecular biology will contribute to WGA market growth. However, the fact that the result of WGA may vary with two different technologies, namely PCR WGA and REPLI-g, used for sequencing, amplifying, and extracting DNA, will probably hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Genome Amplification. The growth and trends of Whole Genome Amplification industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Genome Amplification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Single Cell WGA Kit
Complete WGA Kit
WGA Reamplification Kit
WGA & Chip DNA Kit
Others

By Application

Drug Discovery & Development
Disease Diagnosis
Agriculture & Veterinary
Research
Forensics
Others

By End-User

Pharmaceutical & Biotech Companies
Contract Research
Hospitals & Clinics
Research & Academic Institutes
Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Genome Amplification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Genome Amplification market include Qiagen NV, LGC Group, Sigma-Aldrich, GE Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215177

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WHOLE GENOME AMPLIFICATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Single Cell WGA Kit Historic and Forecast Sales By Regions
5.4. Complete WGA Kit Historic and Forecast Sales By Regions
5.5. WGA Reamplification Kit Historic and Forecast Sales By Regions
5.6. WGA & Chip DNA Kit Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug Discovery & Development Historic and Forecast Sales By Regions
6.4. Disease Diagnosis Historic and Forecast Sales By Regions
6.5. Agriculture & Veterinary Historic and Forecast Sales By Regions
6.6. Research Historic and Forecast Sales By Regions
6.7. Forensics Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
7.4. Contract Research Historic and Forecast Sales By Regions
7.5. Hospitals & Clinics Historic and Forecast Sales By Regions
7.6. Research & Academic Institutes Historic and Forecast Sales By Regions
7.7. Organizations Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE WHOLE GENOME AMPLIFICATION COMPANIES

9.1. Whole Genome Amplification Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF WHOLE GENOME AMPLIFICATION INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Qiagen NV
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. LGC Group
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sigma-Aldrich
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies